Company / AR per Share
Arcadia Biosciences, Inc. AR per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.10
FY2021
5-year range
$0.10 / $0.10
FY2017-FY2021
Trend
-37.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share has fluctuated over the past 6 years, ranging from $0.01 in FY2016 to $0.55 in FY2017.
Based on SEC 10-K filings.
0.10 in FY2021 with a 5-year CAGR of +66.8%.
Declined from $0.13 to $0.10 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +9.6%
- 5-Year CAGR
- +66.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, ar per share decreased 37.4% year-over-year.
- Peak ar per share was recorded in FY2017.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.10 | -37.4% |
| FY2020 | $0.16 | +29.0% |
| FY2019 | $0.13 | +63.1% |
| FY2018 | $0.08 | -86.0% |
| FY2017 | $0.55 | +6906.3% |
| FY2016 | $0.01 | -97.7% |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026